Search research articles
Contact Us
Filters
Showing results (1-10 of 57) with videos related to
Page
of 6
Sort By:
Breast Cancer Research and Treatment
|
May 25, 2010
Overall survival in metastatic breast cancer: always our quest but not necessarily a primary endpoint
Nicholas J Robert
Clinical Breast Cancer
|
July 2, 2017
Patient Case Lessons: Endocrine Management of Advanced Breast Cancer
Nicholas J Robert, Neelima Denduluri
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer
|
May 16, 2024
Abemaciclib-based therapy versus tucidinostat-based therapy in patients with HR<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer after palbociclib progression: insights and challenges from a comparative cohort study in China
Nino Balanchivadze, Nicholas J Robert
Hematology/Oncology Clinics of North America
|
May 22, 2007
HER2-positive advanced breast cancer
Nicholas J Robert, Anne M Favret
Medgenmed : Medscape General Medicine
|
December 22, 2005
Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer
Henning T Mouridsen, Nicholas J Robert
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2005
The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women
Henning T Mouridsen, Nicholas J Robert
Current Oncology (Toronto, Ont.)
|
January 20, 2023
Impact of COVID-19 Pandemic on Non-Small Cell Lung Cancer Care
YiYuan Zhai, Pooja Chopra, David Kang, et al.
Clinical Lung Cancer
|
June 30, 2021
Understanding Contemporary Molecular Biomarker Testing Rates and Trends for Metastatic NSCLC Among Community Oncologists
David M Waterhouse, Wan-Yu Tseng, Janet L Espirito, et al.
Journal of Comparative Effectiveness Research
|
May 29, 2026
Directly comparing randomized and real-world controls in adjuvant breast cancer
Brigham Walker, Marley Boyd, Michelle Silver, et al.
Drugs - Real World Outcomes
|
January 8, 2017
HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes
Nicholas J Robert, Hans-Peter Goertz, Pooja Chopra, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 57) with videos related to
Sort By:
Page
of 6
Breast Cancer Research and Treatment
|
May 25, 2010
Overall survival in metastatic breast cancer: always our quest but not necessarily a primary endpoint
Nicholas J Robert
Clinical Breast Cancer
|
July 2, 2017
Patient Case Lessons: Endocrine Management of Advanced Breast Cancer
Nicholas J Robert, Neelima Denduluri
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer
|
May 16, 2024
Abemaciclib-based therapy versus tucidinostat-based therapy in patients with HR<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer after palbociclib progression: insights and challenges from a comparative cohort study in China
Nino Balanchivadze, Nicholas J Robert
Hematology/Oncology Clinics of North America
|
May 22, 2007
HER2-positive advanced breast cancer
Nicholas J Robert, Anne M Favret
Medgenmed : Medscape General Medicine
|
December 22, 2005
Benefit with aromatase inhibitors in the adjuvant setting for postmenopausal women with breast cancer
Henning T Mouridsen, Nicholas J Robert
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2005
The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal women
Henning T Mouridsen, Nicholas J Robert
Current Oncology (Toronto, Ont.)
|
January 20, 2023
Impact of COVID-19 Pandemic on Non-Small Cell Lung Cancer Care
YiYuan Zhai, Pooja Chopra, David Kang, et al.
Clinical Lung Cancer
|
June 30, 2021
Understanding Contemporary Molecular Biomarker Testing Rates and Trends for Metastatic NSCLC Among Community Oncologists
David M Waterhouse, Wan-Yu Tseng, Janet L Espirito, et al.
Journal of Comparative Effectiveness Research
|
May 29, 2026
Directly comparing randomized and real-world controls in adjuvant breast cancer
Brigham Walker, Marley Boyd, Michelle Silver, et al.
Drugs - Real World Outcomes
|
January 8, 2017
HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes
Nicholas J Robert, Hans-Peter Goertz, Pooja Chopra, et al.
Page
of 6